Triventures — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches.
BiotechHardwareHealthtechMedical DevicesKfar Saba, IL
Boaz Assaf(CEO)in
Co-investorsClal Biotechnology Industries
Company whose CEO and cofounder Xu Zou credited Wisemont as an early investor providing funding and business support.
Mountain View, US
Xu Zou(Executive Officer, Director)Mei Wang(Director)Robert Thomas(Director)Richard Lim(Director)Raman Khanna(Director)in
Co-investorsDell Technologies CapitalInformed Ventures Advisors, LlcPreface VenturesSocial StartsTSVCWisemont Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





